Prudentia at ChinaBIO and BIO International 2026

ChinaBIO Partnering Forum 2026

Prudentia Sciences will be at the ChinaBIO Partnering Forum in Shanghai, April 28-29.

CEO Sadiqa Mahmood will join Stacy Feld, Global Head of External Scientific Innovation at Johnson & Johnson, for a fireside chat exploring what it really takes to build conviction on a China-origin asset in 2026. The conversation will examine how global pharma teams are rethinking diligence, where biotechs most often fall short in positioning their science for partnership, and how emerging approaches to evaluation are compressing timelines and surfacing risk earlier.

Connect with us to learn how Prudentia is transforming due diligence for life sciences dealmaking.

BIO International Convention 2026

Prudentia Sciences will attend the BIO International Convention in San Diego, June 22-25.

As the industry's premier biotechnology gathering, BIO 2026 is a key venue for advancing conversations around smarter, faster dealmaking in life sciences. We look forward to connecting with pharma and biotech leaders shaping the future of partnerships. Additional programming details will be shared as they are confirmed.

Connect with Prudentia Sciences: partner@prudentiasciences.com

More news from Prudentia

3 min read

Introducing Prudentia Intelligence 2.0

Prudentia Intelligence 2.0 extends Prudentia's scientific reasoning frameworks across the full arc of deal strategy, from identifying risk to assessing mitigation to weighing what each finding means for the thesis. CEO Sadiqa Mahmood explains how deeper reasoning, a connected evidence base, and domain-specific workspaces help deal teams build a strategy they can defend.

5 min read

Our Data Stewardship Commitment to Innovators

Every transaction requires disclosure, and every disclosure creates exposure. Sean O'Shea details five commitments the platform's architecture enforces: your competitors never use your data, nothing crosses between customer environments, secondary distribution never happens, your permissions govern, and access stays revocable. Those refusals are what let your science reach the right partner on your terms.